Learn more about your MyOme Pharmacogenomics Report

Understanding Your Pharmacogenomics Report

MyOme Personal Genome Pharmacogenomic Report gives a healthcare provider additional information to help guide drug treatment selection. We recommended you discuss your results with your provider. Frequently asked questions can be found below.

Frequently Asked Questions

  • What factors impact an individual’s response to medication?

  • Why would genetic differences affect how I respond to a medication?

  • Should I change my medication based on this report?

  • Why is there no guidance specific to individual medications on this report?

Contact Us

We are happy to answer any questions. Contact us at info@myome.com with any questions or to keep apprised of any development, provide your name and email information.

footer logo
linkdin

© 2023 MyOme.com

MyOme is not responsible for the content or accuracy of third-party websites

The MyOme Personal Genome Report was developed, and its performance characteristics were determined, by MyOme, Inc., a clinical laboratory certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high complexity clinical laboratory testing. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary for laboratory-developed tests.